2010•Journal of Modern Clinical MedicineRequires access

The Clinical Diagnostic Value of joint inspection of Serum CEA、CA19-9、CA125 in the Patients with Ovarian Cancer

Liao Jia-xu

Abstract

Objective:To study the clinical diagnostic value of joint inspection of serum CEA,CA19-9 and CA125 in patients with ovarian cancer.Methods:Serum CEA,CA19-9 and CA125 were measured with MLEIA in 75 patients with ovarian cancer and 50 controls.Results:The level of serum CA19-9 and CA125 on tumor markers in patients with ovarian cancer were significantly higher than that in controls(P0.05).Positive rate of single marker was:CEA(5.3%),CA19-9(48.0%) and CA125(64.0%).Joint inspection of the three marker increased the positive rate to 92.0%.Conclusion:The joint inspection of serum CEA,CA19-9 and CA125 can improve the diagnostic positive rate of ovarian cancer apparently.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Ovarian cancer, Tumor marker, CA19-9, Internal medicine, Oncology, Cancer antigen, Cancer